Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XTORO safely and effectively. See full prescribing information for XTORO. XTORO (finafloxacin otic suspension) 0.3%,for topical otic use Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
XTORO® is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus in patients age 1 year and older.
- generic_name
- finafloxacin
- product_names
- finafloxacin
- ndc
- 83709-001, 83709-001-01, 83709-001-91, 83709-001-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en